Researchers in Taiwan have developed a new targeted therapy drug that preclinical trials suggest could inhibit the growth of tumors in nearly 30 percent of cancer patients.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
U.S. dollar lower in Taipei trading
12/04/2025 10:15 AM - Society
Taiwan headline news
12/04/2025 10:12 AM - Business
Taiwan shares open lower
12/04/2025 09:15 AM - Society
- Society
Mercury to drop to 15°C early Thursday, before rebounding over the weekend
12/03/2025 09:48 PM